ORGANIZING AND SCIENTIFIC COMMITTEES Congress Director: Scientific Committee: Dr. Francisco Dasí Dr. Salvador Aliño Organizing Committee: Dr. Antonio Alberola Dr. Amparo Escribano Dr. Ignacio Blanco Dr. Estrella Fernández-Fabrellas Dr. Carmen Carda Dr. Miguel Armengot Dr. Rafael Carmena Dr. Francisco Sanz Dr. Francisco Casas Dr. Carolina Moreno Dr. Pilar Codoñer-Franch Dr. Silvia Castillo Dr. Julio Cortijo Ms. Sara Pastor Dr. Joaquín Donat Ms. Ana Reula Dr. Ismael Ejarque Ms. Silvia Vicente Dr. Gemma Espí Ms. Ana Isabel Ahullana Dr. Rafael Fernández-Delgado Ms. Mercedes Navarro Dr. Esteban Morcillo Dr. Federico Pallardó Dr. Rafael Peris Dr. Juan José Soler Dr. María Torres PRELIMINARY PROGRAMME Day I: Wednesday, February 17th 2016 Time 08:00 – 09:00 09:00 – 09:15 09:15 – 10:00 Activity Place Speakers Institution School of Medicine (Hall) Registration Opening ceremony Rare Respiratory Diseases Aula Magna Dr. Zurriaga; Dr. Alfageme Dr. Morcillo; Dr. Pallardó; Dr. Navarro. Conselleria de Sanitat Universitat de Valencia Facultad de Medicina-UV Aula Magna Dr. Matthias Griese Childrens’ Hospital of the Ludwig-MaximiliansUniversity (MunichGermany) CYSTIC FIBROSIS (Coordinator: Amparo Escribano MD PhD) 10:00 – 10:25 ROUND TABLE Where are we from? Where are we going? Moderator: Dra. Concha Prados. President of the Spanish Society of Cystic Fibrosis Natural history of the disease: Changes, achievements and milestones Dr. Amparo Hospital Clínico, Valencia Aula Magna in the last 70 years Escribano (Spain) 10:25 – 10:50 Current treatment of cystic fibrosis Aula Magna 10:50 – 11:00 Discussion Aula Magna Dr. Esther Quintana Hospital Virgen del Rocío, Sevilla (Spain) Ms. Yasmina Costa President of the Valencian Association of Cystic Fibrosis COFFEE BREAK 11:30 – 12:15 12:15 – 12:45 12:45 – 13:15 13:15 – 13:30 Vision of patients affected by cystic fibrosis: The long road to Ithaca Aula Magna ROUND TABLE The future is already here Moderator: Dr. Amparo Solé. President of the Spanish Foundation of Cystic Fibrosis CFTR Protein Repair Therapy in Unidad FQ. Hospital Univ. Cystic Fibrosis. The Spanish Aula Magna Dr. Carmen Luna 12 de Octubre. Madrid experience with Ivacaftor (Kalydeco) (Spain) Current state of research in the Dr. Pedro Unidad FQ. Hospital treatment of F508del mutation and Aula Magna Mondejar Clínico Univ. Virgen de other common mutations Arreixaca. Murcia (Spain) Discussion Aula Magna LUNCH IDIOPATHIC PULMONARY FIBROSIS (Coordinator: Estrella Fernández Fabrellas MD PhD) 15:30 – 16:00 16:00 – 16:30 16:30 – 17:00 Discovering the pathogenesis of IPF Recent approaches in the diagnosis of IPF Prognostic factors for IPF Aula Magna Aula Magna Aula Magna Dr. María Molina Dr. Estrella Fernández Dr. Elena Bollo Hospital Universitari de Bellvitge, Barcelona (Spain) Hospital General, Valencia (Spain) Complejo Hospitalario de León (Spain) COFFEE BREAK 17:30 – 18:00 What is going on in translational research in FPI? Aula Magna Dr. Serrano-Mollar 18:00 – 18:30 FPI in real life: clinical cases Aula Magna Dr. José Antonio Rodríguez Portal Instituto de Investigaciones Biomédicas, Barcelona (Spain) Hospital Virgen del Rocío, Sevilla (Spain) Day II: Thursday, February 18th 2016 Time Activity Place Speakers Institution ALPHA-1 ANTITRYPSIN DEFICIENCY (AATD) (Coordinator: Francisco Dasí PhD) 10:00 – 10:30 10:30 – 11:00 11:00 – 11:30 The natural history of AATD AATD treatment and management Aula Magna Aula Magna Aula Magna 12:00 – 12:30 12:30 – 13:00 13:00 – 14:00 Thinking of the unknown Translational research in AATD Clinical cases in AATD Aula Magna Aula Magna Aula Magna Diagnosis of AATD Dr. Adolfo Baloira Dr. Beatriz Martínez Dr. Marc Miravitlles Complexo Hospitalario Pontevedra (Spain) Intituto de Salud Carlos III, Madrid (Spain) Hospital Vall d’Hebrón, Barcelona (Spain) COFFEE BREAK Dr. Ángeles Requena Dr. Francisco Dasí Dr. María Torres and López-Campos Hospital de Hellín, Albacete (Spain) FIHCUV/IIS INCLIVA, Valencia (Spain) Complexo Hospitalario de Vigo y H. U. Virgen del Rocio, Sevilla (Spain). LUNCH 15:30 – 16:00 16:00 – 16:30 16:30 – 17:00 PRIMARY CILIARY DYSKINESIA (PCD) (Coordinator: Miguel Armengot MD PhD) Primary ciliary dyskinesia: Aula Historical development from its Dr. Jane Lucas Magna discovery to the current concept Primary ciliary dyskinesia: Aula Dr. Xavi Milara Genetics and future prospects Magna Aula Research in PCD Dr. Jane Lucas Magna University of Southampton (UK) Hospital General, Valencia University of Southampton (UK) COFFEE BREAK 17:30 – 18:00 Clinical manifestations in adults and children. Lung, sinus and ear disease. Evolution and prognosis. Aula Magna Dr. Antonio Moreno 18:00 – 18:30 Clinical cases in PCD Aula Magna Dr. Miguel Armengot 18:30 – 19:00 It's time for patients 19:00 Closing ceremony Mr. Tomás Castillo Aula Magna Drs. Amparo Escribano; Estrella Fernández; Miguel Armengot; Francisco Dasí Hospital Vall d’Hebrón (Spain) Hospital General, Valencia (Spain) President of the platform of patient’s organizations HCUV-Malvarrosa Hospital General INCLIVA (Spain)
© Copyright 2024